In last trading session, Altimmune Inc (NASDAQ:ALT) saw 4.97 million shares changing hands with its beta currently measuring -0.00. Company’s recent per share price level of $4.05 trading at -$0.13 or -3.11% at ring of the bell on the day assigns it a market valuation of $328.49M. That closing price of ALT’s stock is at a discount of -175.56% from its 52-week high price of $11.16 and is indicating a premium of 28.4% from its 52-week low price of $2.90. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 8.17 million shares which gives us an average trading volume of 5.55 million if we extend that period to 3-months.
For Altimmune Inc (ALT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.60. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Altimmune Inc (NASDAQ:ALT) trade information
Altimmune Inc’s shares saw a change of -48.73% in year-to-date performance and have moved -7.95% in past 5-day. Altimmune Inc (NASDAQ:ALT) showed a performance of -41.05% in past 30-days. Number of shares sold short was 24.4 million shares which calculate 8.05 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 25 to the stock, which implies a rise of 83.8% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 35. It follows that stock’s current price would drop -196.3% in reaching the projected high whereas dropping to the targeted low would mean a loss of -196.3% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 3.48% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 7.66% while estimates for its earnings growth in next 5 years are of 2.73%.
Altimmune Inc (NASDAQ:ALT)’s Major holders
Insiders are in possession of 0.76% of company’s total shares while institution are holding 47.85 percent of that, with stock having share float percentage of 48.22%. Investors also watch the number of corporate investors in a company very closely, which is 47.85% institutions for Altimmune Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at ALT for having 5.32 million shares of worth $35.39 million. And as of 2024-06-30, it was holding 7.5025 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 4.91 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.9181 of outstanding shares, having a total worth of $32.63 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 2.24 shares of worth $9.06 million or 2.76% of the total outstanding shares. The later fund manager was in possession of 1.81 shares on May 31, 2025 , making its stake of worth around $7.32 million in the company or a holder of 2.23% of company’s stock.
